Join
Live feed
·
PRReleasevia Quantisnow
Jazz Pharmaceuticals plc logo
Zymeworks Inc. logo

Zymeworks To Host Conference Call on Exclusive Licensing Agreement of Zanidatamab

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track JAZZ (Jazz Pharmaceuticals plc), ZYME (Zymeworks Inc.) and more on Quantisnow.